Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer

Avania

BILTHOVEN, Netherlands & BOSTON–BUSINESS WIRE–

Avania, the leading global MedTech advisory and clinical development partner, today announced the appointment of operational strategy expert Charlene Dark as chief operating officer (COO).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203677092/en/

Charlene Dark, newly appointed chief operating officer of Avania. </div> <p>Dark brings over 30 years of experience driving forward-thinking, risk-based strategies that fuel growth and profitability in the clinical development sector. She previously served as executive vice president of global clinical analytics at Clinipace, now Caidya, where she successfully drove commercial growth and operational efficiency of its global clinical analytics solution and spearheaded the development and adoption of the data aggregation and analytics offering. </p> <p>

“As Avania guides sponsors through every stage of their product’s life cycle, Charlene’s data-driven decision-making, grounded in extensive clinical development experience, will be an asset to our clients and team,” Jason Monteleone, Avania president and CEO, said. “She plays a critical role in our next phase of growth supporting a flexible operating model that meets the diverse needs of our sponsors.”

About Avania

Avania is the leading global MedTech advisory and clinical development partner with a focus on medical devices, diagnostics/IVDs, and digital health. Core offerings include full service clinical research outsourcing, market access, reimbursement, regulatory, and product development advisory services. Avania’s vision is to be your trusted global partner in the evolution of your medical technology from innovation to commercialization to improving patient health and well-being. When you need to advance your medical technology, It Takes Avania.